Evaluation of Thyroid Functions with Respect to Iodine Status and TRH Test in Chronic Autoimmune Thyroiditis by Ergür, Ayça Törel et al.
J Clin Res Ped Endo 2011;3(1):18-21
DOI: 10.4274/jcrpe.v3i1.04
Ayça Törel Ergür1,  Olcay Evliyao¤lu2,  Zeynep ﬁ›klar2, Pelin Bilir2, Gönül Öcal2, Merih Berbero¤lu2
1Ufuk University School of Medicine, Department of Pediatric Endocrinology, Ankara, Turkey
2Ankara University School of Medicine, Department of Pediatric Endocrinology, Ankara, Turkey
Address for Correspondence
Ayça Törel Ergür, Ufuk University School of Medicine, Department of Pediatric Endocrinology, Ankara, Turkey
Gsm: +90 312 266 67 78  E-mail: aycaergur@superonline.com
© Journal of Clinical Research in Pediatric Endocrinology, Published by Galenos Publishing.
Evaluation of Thyroid Functions with Respect to





Primary acquired childhood and juvenile hypothyroidism
is mainly due to chronic autoimmune thyroiditis (CAT) (1).
Because of the risk of hypothyroidism, the disease requires
lifelong thyroid surveillance, especially in women of 
child-bearing age in order to avoid adverse effects on the
expected child. The aim of this study was to evaluate 
the clinical and laboratory features of CAT in childhood and
adolescence in our patient population mainly with respect 
to iodine levels and thyroid status as well as to diagnostic
values of thyrotropin-releasing hormone (TRH) test.
Methods
Seventy-one children with a mean age of 11.6±2.7
(range: 5.4-17.5) years were studied in a retrospective 
analysis. All cases were evaluated with a detailed physical
examination, pubertal staging (according to Tanner staging),
and height and weight measurements. Height was
expressed as standard deviation score (SDS) (2). Body mass
index (BMI) was calculated as: weight (kg)/height (m)2.
Cases with a height below -2 SDS were considered to have
a short stature and those with BMI above >95th were 
considered obese (2,3). Relative BMI was calculated by
dividing the individual's BMI to normal BMI adjusted for sex
and age (100% x individual's BMI/sex- and age-specific BMI
cut-offs from a reference population) (3).
ABSTRACT
Objective: Chronic autoimmune thyroiditis (CAT) is the most common
form of thyroiditis in childhood and a frequent cause of acquired
hypothyroidism. The objective of this study was to evaluate  the thyroid
status of children and adolescents with CAT with respect to iodine 
status and diagnostic values of thyrotropin-releasing hormone (TRH)
test.   
Methods: Seventy-one children (mean age: 11.6 years) were studied in
a retrospective analysis. Free thyroxine (T4), thyrotropin (TSH), TSH
response to TRH test, thyroid autoantibodies, thyroid sonography, and
urinary iodine excretion (UIE) were evaluated.  
Results: At diagnosis, 8.5% of patients had overt hypothyroidisim and
36.6% subclinical hypothyroidism; 5.6% had overt hyperthyroidisim 
and 8.5% had subclinical hyperthyroidism. Of them, 40.8% were 
euthyroid. Median UIE was 51 μg/L in overt hypothyroidism and 84 μg/L
in subclinical hypothyroidism. The values were 316 μg/L and 221 μg/L
in overt and subclinical hyperthyroidism, respectively. Basal TSH
showed a strong correlation with peak TSH level on TRH test. Thirty-
four percent of patients with normal basal TSH level showed an 
exaggerated TSH response. 
Conclusion: Iodine deficiency was seen more in cases with 
hypothyroidism, while excess of iodine was observed to be more 
frequent in hyperthyroid patients. Iodine status was a strong predictor
of the thyroid status in CAT. TRH test may be helpful in further 
delineating patients with subclinical hypothyroidism.   
K Ke ey y   w wo or rd ds s: : Chronic autoimmune thyroiditis, childhood, adolescent,
C Co on nf fl li ic ct t   o of f   i in nt te er re es st t: : None declared
R Re ec ce ei iv ve ed d: : 31.10.2010 A Ac cc ce ep pt te ed d: : 07.02.2011The thyroid gland was assessed by palpation 
and graded according to the goitre classification system
proposed by the World Health Organization (WHO) (4).
Serum free triiodothyronine (T3), free thyroxine (T4), 
thyrotropin (TSH), antithyroglobulin (anti-TG), antithyroid
peroxidase antibody (anti-TPO) were measured in all
patients. Serum free T3, free T4 levels were determined by
competitive immunoassay method using immunodiagnostic
products  (5). Serum TSH levels were measured by 
immunometric radioimmunoassay (IRMA) method. Anti-TG
and anti-TPO were measured using immunometric assay
method (Immulite 2000®, DPC, Los Angeles) .Values above
35 U/ml for anti-TG and above 40 U/ml for anti-TPO were
considered positive (6). Standard TRH test (7) ( giving TRH
in a dose of 5-7 μg/kg body weight and measuring TSH at
0, 20, 40 and 60 minutes) was performed  in all patients 
without overt hypothyroidism or overt hyperthyroidism.
Overt hypothyroidism was accepted in the presence of high
basal TSH level with low T4 level. Patients with subclinical
hypothyroidism had normal T4 and elevated basal TSH. 
The diagnosis of hyperthyroidism was established in the
presence of suppressed basal TSH level (TSH below 0.5
mIU/ml) with high (overt hyperthyroidism) or normal 
(subclinic hyperthyroidism) T4 level. TSH response to TRH
was considered normal if the peak TSH level was between
5-25 mIU/L. A peak value above 25 mIU/L was considered
as exaggerated and a value below 5 mIU/L as suppressed (7).
Thyroid sonography was performed by high-resolution
ultrasound using 7.5 MHz probes in each patient. Thyroid
volumes were calculated by the Neu’s reference criteria (8).
Longitudinal and transverse scans were performed allowing
the measurement of the depth, length and width of each
lobe. Thyroid volume was taken as the sum of the volumes
of the two lobes. The volume of the isthmus was 
not included. Accordingly, cases with thyroid volumes
above 97th percentile were accepted to have goitre (9). The
diagnosis of CAT on ultrasonographic evaluations  included
varying degree of hypoechogenicity, heterogeneous
parenchyma, peppered with innumerable small hypoechoic
nodules measuring a few millimeters and separated by
echogenic septae (10).
Morning urinary samples were taken from all patients
for determination of urinary iodine excretion (UIE) 
which was measured by colorimetric method suggested by
WHO-ICCIDD (11). The prevalence of iodine deficiency was
graded according to the WHO classification (12). UIE levels
between 100 and 200 μg/L were accepted as normal. Mild,
moderate or  severe iodine deficiency was present when
UIE was 50-99 μg/L, 20-49 μg/L, or <20 μg/L, respectively.
A value greater than 200 μg/L indicated excessive urinary
iodine.
LT4 treatment was initiated in cases whose thyroid
gland was over +2 SDS and in cases with overt or 
subclinical hypothyroidism or with normal basal TSH levels
but with exaggerated TSH response on TRH test. 
Statistical analysis was performed using the Statistical
Package for the Social Sciences (SPSS) version 10.0 for
Windows. The values for continuous variables have been
shown as the mean (SDS) and median. 
Results
The mean age of the patients at diagnosis was 11.6±2.7
years, height SDS was -0.3±0.8 SDS, BMI was
95.7±14.4%. Twenty-two out of the seventy-one 
patients (30%) were prepubertal. There was a female 
preponderance (n=61, 85.9%). All children had palpable
goitre. The goitre stages were 1a in 13%, 1b in 28%, II in
42%, and III in 16.9%. Two cases had short stature with
hypothyroidism. Obesity was encountered in six patients
(8.5%), four of whom had also subclinical hypothyroidism.
Twenty percent had a family history of thyroid disease. 
The severity of iodine deficiency according to the 
median UIE in all patients is shown in Table 1. Iodine 
deficiency was determined in 59.1% of the total group.
Excessive urinary iodine concentration was observed 
in 12.7%.  
As for the thyroid functions at diagnosis, 6 patients
(8.5%) had overt hypothyroidism with high TSH levels, nine
(36.6%) had borderline increased levels of TSH (between 5
to 10 mIU/ml) and normal fT4 levels, and 38 children
(40.8%) had normal basal thyroid hormone and TSH 
levels. Ten patients had suppressed TSH levels, with 
normal thyroid hormone levels in 6 (8.5%) (subclinical
hyperthyroidisim) and with high thyroid hormone levels 
in 4 (5.6%) (overt hyperthyroidism) (Figure 1). TRH 
stimulation test was applied to 61 patients without overt
hypothyroidism or overt hyperthyroidism. Stimulated 
TSH response positively correlated with basal TSH 
levels (r=0.88, p<0.000). UIE negatively correlated with
stimulated TSH levels (r=-0.35, p=0.014). The response to
TRH test according to basal TSH level and UIE are shown in
Table 2. Patients (34%) with normal basal TSH levels had an
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Table 1. The iodine status in the CAT patients
Iodine  status Patient number   Median (min-max)
(%) UIE  (μg/L )
Mild deficiency of iodine 26 (36.61 %) 79 (52-97)
Moderate deficiency of iodine 9 (12.67%) 46 (24-49)
Severe deficiency  of iodine 7 (9.85%) 9.5 (1-18)
Excess of iodine  9 (12.67%) 387 (220-450)
UIE: urinary iodine excretion
CAT: chronic autoimmune thyroiditisexaggerated TSH response on TRH test. Moreover, of
those with basal TSH levels between 2 and 5 mIU/mL, 50%
had an exaggerated TSH response. According to thyroid
dysfunction types, the median UIE values are shown in
Table 3. Iodine deficiency was prevalent in CAT patients
who had overt or subclinical hypothyroidism and iodine
excess in hyperthyroidism.
Anti-TG antibodies were positive in 80.3% (n=58) 
and anti-TPO antibodies in 71.8% (n=51) of subjects. Both
antibodies were positive in 53.5% patients (n=38). TSH
receptor antibodies (TRAb) were negative in all patients. 
On thyroid USG, a heterogeneous parenchymal 
structure was observed in 58% of  patients and nodules
were noted in 7% of cases. 
Patients on LT4 treatment have been followed up for
3.26±2.8 years.  The LT4 therapy was not given to 10 cases
at admission, but was started after a follow-up of 0.9±0.6
years because hypothyroidism developed. Hyperthyroidism
did not persist in any of the subclinical or overt hyperthyroid
patients. 
Discussion
CAT  is one of very frequently seen thyroid pathologies
which may lead to thyroid dysfunction, particularly 
hypothyroidism (13). 
The general clinical features of the patients and the 
percentage of family history in our study are consistent with
the published in the literature (14). However, we observed
a relatively higher rate of thyroid dysfunction than cited in
the literature (15), which may be due to the concomitant
presence of iodine deficiency in our series.
Indeed, in another study conducted in our country,
24.1% of CAT patients (n=162) had compensated 
hypothyroidism, 21% had overt hypothyroidism, 
8.6%-overt hyperthyroidism, and 3.1% had subclinical
hyperthyroidism (16). The rate of thyroid dysfunction in CAT
may be high in Turkey (17).
In our study, CAT was accompanied by iodine deficiency
in 50% of cases. While iodine deficiency was seen more in
cases of hypothyroidism, excess of iodine was observed to
be more frequent in hyperthyroid patients. Iodine deficiency
seems to increase the risk of hypothyroidism. Euthyroid
patients had almost normal UIE. In CAT patients showing
either overt or subclinical hypothyroidism, iodine excess
was frequently seen instead of iodine deficiency. It is well
known that iodine-induced hyperthyroidism may occur in
patients with iodine-deficiency goitre, in euthyroid Graves’
disease patients after antithyroid drug therapy, in euthyroid
subjects with previous spontaneous and iatrogenic
episodes of thyroid dysfunction, in patients with multinodular
20
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Table 2. TSH response to TRH test according to basal TSH
Basal TSH (mIU/ml) n Urinary iodine excretion  TRH-stimulated TSH (mIU/ml) Exaggerated TSH response
median (min-max) median (min-max) (>25 mIU/ml) to TRH test (%)
<0.5 (no overt hyperthyroidism) 6 286 (97-450) 2.15 (0.003-8.7)  0% (0/6)
0.5-5  38 110 (1-450) 23.35 (9.74-46.4) 34% (13/38)
0.5-2  15 138 (1-450) 22.4 (9.74-31.9) 13% (2/15)
2-5  23 90 (1-150) 28.1 (13.57-46.4) 48% (11/23)
5-10   9 78 (11-144) 38.2 (20.1-44.9) 78% (7/9)
>10 (no overt hypothyroidism)  9 66 (24-122) 68.5  (44-110)  100% (9/9)
TSH: thyrotropin, TRH: thyrotropin-releasing hormone
Table 3. Iodine status in different thyroid dysfunction types
Thyroid dysfunction n   UIE  (μg/L ) median 
(min-max)
Overt hypothyroidism 6 51 (24-122)
Subclinical hypothyroidism 26 84 (1-150)
Overt hyperthyroidism 4 316 (220-450)
Subclinical hyperthyroidism 6 221 (97-450)
UIE: urinary iodine excretion Figure 1. Thyroid status  in the CAT patients













0goitres who reside in areas of iodine repletion or deficiency
(18). Hyperthyroidism was transient in our CAT patients,
and none of them had positive TRAb; therefore, there was
no coexistence of CAT and Graves’ diseases.  
In the presence of autoimmune  thyroid disease, the
control of UIE may be  helpful in predicting probable thyroid
dysfunction and may lead our recommendation on the use
of iodized salt. Some researchers suggest that increase in
iodine intake triggers autoimmunity and may increase CAT
prevalence (19). However, our findings do not verify this
observation since a substantial number of children had
iodine deficiency. The rate of positive antibodies in our
study is relatively similar to the rates cited in the literature
(15,16).
As for LT4 therapy during childhood in CAT patients
with subclinical hypothyroidism, no controlled studies have
been reported in the literature. Assuming that development
may be affected adversely, LT4 treatment was initiated 
in such cases in this study. We believe that the follow-up
evaluation of these children will  have a significant role from
this standpoint. Another important finding is that basal TSH
showed a very strong association with peak TSH level on
TRH test and this may lead to the conclusion that a TRH
test is not needed to assess the thyroid status. Indeed, in
those with suppressed TSH or increased basal TSH levels,
TRH test does not seem to further add to the diagnosis.
However, nearly one third of our patients with normal 
TSH levels had an exaggerated TSH response on TRH test.
Especially those with a TSH level between 2 and 5mIU/mL
had frequently an exaggerated TSH response. Future 
long-term studies and follow-up of these children are 
needed to explore whether this implies an abnormality.
In conclusion, iodine status has an effect on the thyroid
functions in CAT. TRH test may help identifying patients
with subclinical hypothyroidism. 
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